Moreover, if positive, the TETON data in idiopathic pulmonary fibrosis which is expected soon ... many years in the clinic and in patients' hands and in essentially about 24 months or so to ...

The outcomes of patients with idiopathic pulmonary fibrosis (IPF) remain unknown. Alongside the global adoption of antifibrotic therapies, there is currently relentless research for biomarkers and ...

Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies seeking to advance ...

An already approved cancer drug, Yervoy (ipilimumab), improved lung repair ability in a study of mice with idiopathic ...

Idiopathic pulmonary fibrosis was associated with 67,843 deaths in ever-employed persons in the US between 2020 and 2022.

In idiopathic pulmonary fibrosis, higher risk of mortality and lung transplant is linked to small decreases in FVC% predicted and DLCO% predicted.

Last September, the FIBRONEER-IPF trial also showed an improvement in lung function with the drug in patients with idiopathic pulmonary fibrosis (IPF), another ILD subtype that tends to be less ...

New guidelines for cystic fibrosis screening in newborns improve sensitivity, equity, and timeliness of diagnosis.

Ipilimumab, a cancer immunotherapy, reduced scar formation and promoted tissue regeneration in a mouse model of idiopathic ...

The expert shared that the "distinctive blue hands of the timepiece perfectly complement the deep blue of her ring, creating a subtle yet elegant harmony." ...